Building a better system for cancer care is a job too big for one organization, no matter how dedicated its staff may be. Given that reality, FCS partners with organizations such as the Community Oncology Alliance (COA).
Center for Medicare & Medicaid Innovation developed the Oncology Care Model, a national payment program that provides high-caliber, efficiently managed cancer care at a lower price.
Florida Cancer Specialists & Research Institute (FCS) announces that Tonja A. Wise, MHA, CHC, CHPC, CCS has joined its senior management team as Vice President of Compliance.
The American Cancer Society reported earlier this year that the risk of dying from cancer in the United States has decreased by 32% over the past 28 years, which translates to almost 3.5 million fewer cancer deaths. Over these nearly three decades, cancer treatment options have increased immensely. For example, oral oncolytic medications now enable patients to receive therapies that target specific mutations in their tumors in pill form, replacing time-intensive chemotherapy infusions and minimizing side effects. New technologies, such as genome testing and artificial intelligence, have sharpened our view of cancer.
Michael Diaz, MD and Faithlore Gardner, MD from Florida Cancer Specialists & Research Institute (FCS) participated in the Florida Society of Clinical Oncology (FLASCO) Fellow & Resident Educational Training Program held March 19, 2022 in Orlando, Florida.
Florida Cancer Specialists & Research Institute (FCS) launched a new website, Florida Cancer Specialists Hematology Oncology Review (FCSHemOncReview.com), to host a variety of top articles ranging from recent oncology and hematology studies to new therapies, even topics on value-based care.
FCS Top News Updates
FCS Drug Development Research Featured at ESMO Congress 2026